Intravenous immunoglobulin for dysphagia of inclusion body myositis.
Cherin
P
P
Service de Médecine Interne I, Hôpital Salpetriere, Paris, France. patrick.cherin@psl.ap-hop-paris.fr
Pelletier
S
S
Teixeira
A
A
Laforet
P
P
Simon
A
A
Herson
S
S
Eymard
B
B
D000368:Aged; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D003680:Deglutition Disorders / Q000188:drug therapy* / Q000503:physiopathology; D004947:Esophagus / Q000503:physiopathology*; D005260:Female; D006801:Humans; D016756:Immunoglobulins, Intravenous / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D018979:Myositis, Inclusion Body / Q000150:complications* / Q000188:drug therapy / Q000503:physiopathology; D011241:Prednisone / Q000627:therapeutic use
D000893:Anti-Inflammatory Agents; D016756:Immunoglobulins, Intravenous; D011241:Prednisone